Replimune aims to raise $125M; Otsuka makes another deal with Ionis

Plus, news about Kanglin Biotechnology, Seelos, Orbus and Sonata:

Replimune’s $125M offering: The biotech announced the offering four days after it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

RIT researcher receives award to understand the effects of cortical blindness

Rochester Institute of Technology’s Gabriel Diaz, associate professor in the Chester F. Carlson Center for Imaging Science, has earned the Research to Prevent Blindness/Lions Clubs

September 14, 2023

New weight loss drugs have proven their effectiveness. Now researchers want to know how to best use them

LONDON — Starting in the new year, a team of researchers in the U.K. and Denmark will begin recruiting patients for a study driven by

December 26, 2023

Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

Patients with metastatic urothelial carcinoma who achieved a complete response after more than 8.5 months of single-agent enfortumab vedotin (Padcev) were able to be off

November 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.